Clear Search

Advocacy Update

·
10 MIN READ

May 19, 2023: National Advocacy Update

 Senate Committee passes bipartisan PBM legislation and more in the latest National Advocacy Update.
Narcan nasal spray

Overdose Epidemic

·
4 MIN READ

Narcan lands OTC approval: What it means for patients, doctors

The drug’s manufacturer and retailers must help ensure the lifesaving opioid overdose-reversal medication is widely available at an affordable price. 
Physician checking in on patient in bed

Patient Support & Advocacy

UPDATED
·
7 MIN READ

AMA advocacy efforts

The AMA advocates at the federal and state levels on key health care issues impacting patients and physicians. See updates of some of the recent efforts.

Overdose Epidemic

·
12 MIN READ

Naloxone: FDA approves over-the-counter Narcan nasal spray with Bobby Mukkamala, MD

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about Narcan, the over-the-counter naloxone nasal spray, and more.

Overdose Epidemic

·
12 MIN READ

Naloxone: FDA approves over-the-counter Narcan nasal spray with Bobby Mukkamala, MD [Podcast]

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about Narcan, the over-the-counter naloxone nasal spray, and more.
Katherine Pannel, DO

Overdose Epidemic

·
6 MIN READ

How this DO’s advocacy will help prevent drug-overdose deaths

AMA member Katherine Pannel, DO, helped persuade lawmakers to decriminalize fentanyl test strips in Mississippi. Learn more.

Advocacy Update

·
12 MIN READ

April 7, 2023: National Advocacy Update

Long-sought Medicare payment proposal introduced and more in the latest National Advocacy Update.

Publications & Newsletters

·
4 MIN READ

Top news stories from AMA Morning Rounds®: Week of March 27, 2023

In the news: FDA rule on salt substitutes, undiagnosed atrial fibrillation in the U.S., Narcan (naloxone) to be available over the counter and more.

Press Releases

·
2 MIN READ

AMA statement on making naloxone available over the counter

The AMA strongly supports the FDA decision to make the opioid overdose-reversing drug naloxone available over the counter, a position we have long championed.

Membership Moves Medicine™

  • Free access to JAMA Network™ and CME
  • Save hundreds on insurance
  • Fight for physicians and patient rights
Join the AMA today